Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (161-170 of 385) with videos related to

Pageof 39
Sort By:
Haematologica|May 27, 2014
Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterationsMichael W M Kühn, Lars Bullinger, Stefan Gröschel, et al.
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Blood|December 21, 2021
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trialChristopher Maximilian Arends, Savvina Dimitriou, Arndt Stahler, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphomaCharlotte Junkuhn, Phillip Schiele, Anna Luzie Walter, et al.
Haematologica|March 30, 2013
HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapyGlenda J Dickson, Fabio G Liberante, Laura M Kettyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemiaAndrea Corbacioglu, Claudia Scholl, Richard F Schlenk, et al.
Genome Biology|June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Genome Biology|April 16, 2026
Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Patient Education and Counseling|July 8, 2023
Personalizing precision medicine: Patients with AML perceptions about treatment decisionsÅsa Grauman, Mika Kontro, Karl Haller, et al.
Pageof 39

Showing results (161-170 of 385) with videos related to

Sort By:
Pageof 39
Haematologica|May 27, 2014
Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterationsMichael W M Kühn, Lars Bullinger, Stefan Gröschel, et al.
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Blood|December 21, 2021
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trialChristopher Maximilian Arends, Savvina Dimitriou, Arndt Stahler, et al.
Journal for Immunotherapy of Cancer|April 10, 2025
Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin's lymphomaCharlotte Junkuhn, Phillip Schiele, Anna Luzie Walter, et al.
Haematologica|March 30, 2013
HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapyGlenda J Dickson, Fabio G Liberante, Laura M Kettyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemiaAndrea Corbacioglu, Claudia Scholl, Richard F Schlenk, et al.
Genome Biology|June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Genome Biology|April 16, 2026
Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Patient Education and Counseling|July 8, 2023
Personalizing precision medicine: Patients with AML perceptions about treatment decisionsÅsa Grauman, Mika Kontro, Karl Haller, et al.
Pageof 39